Metraipolis › archive › dc_c433ea705f1e

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma — Europe PMC PMID:41375005

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41375005
DOI: 10.3390/cancers17233804
License (as archived): solo-consultazione
Archived: 2026-11-08T05:00:02.831Z
SHA-256 of the archived text: 89c6bfa325ceb124e9acf21b297c7933d463fe748016a75f59b3f7865ed52901
Stable URL of this page: https://metraipolis.com/documento/dc_c433ea705f1e

How to cite

Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma — Europe PMC PMID:41375005 — Europe PMC (en), https://europepmc.org/article/MED/41375005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c433ea705f1e (Metraipolis archive dc_c433ea705f1e, sha256 89c6bfa325ceb124e9acf21b297c7933d463fe748016a75f59b3f7865ed52901)

BibTeX

@misc{dcc433ea705f1e,
  title = {Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma — Europe PMC PMID:41375005},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375005},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c433ea705f1e; sha256 89c6bfa325ceb124e9acf21b297c7933d463fe748016a75f59b3f7865ed52901},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375005. Agents can read the archived copy with the MCP tool read_document.